Attovia Therapeutics, Inc. (ATTO) has another notable name on its insider buying ledger. venBio Global Strategic Fund IV, L.P., listed as an insider of the company, purchased 382,352 shares on the open market on August 6, 2026, at a price of $17.00 per share. The transaction totaled $6,499,984.00, funded directly by the fund rather than … Read more
51Talk Online Education Group (NYSE: COE) disclosed another insider purchase from its top executive, extending a buying pattern that has now stretched across more than a week. According to a Form 4 filing, Huang Jack Jiajia, who serves as Chief Executive Officer, Director, and a 10%+ owner of the company, bought 158,460 shares on August … Read more
A newly filed Form 4 shows James B. Tananbaum, an insider at Latigo Biotherapeutics, Inc. (LTGO), purchased 140,000 shares of the company on the open market on August 10, 2026. The transaction was executed at $18.00 per share, for a total outlay of $2,520,000.00 out of the insider’s own funds. Unlike option exercises or grants … Read more
AppTech Payments Corp. (APCX) director Albert L. Lord disclosed another open-market purchase in a Form 4 filing, adding to a buying pattern that has drawn attention from insider-trading trackers over the past week. According to the filing, Lord purchased 20,000 shares on August 7, 2026, at a price of $0.40 per share, for a total … Read more
A fresh Form 4 filing shows Mateen Justin, an insider at American Bitcoin Corp. (ABTC), purchased 162,438 shares of the company on the open market on August 6, 2026. The transaction was executed at $6.19 per share, for a total outlay of $1,005,052.64 paid from personal funds. Following the purchase, Justin’s directly held stake in … Read more
A newly filed Form 4 shows MA Eagle II Holdings Fund, listed as an insider of MA Specialty Credit Income Fund (SCISX), made a sizable open-market purchase of the fund’s shares. The transaction, dated August 6, 2026, involved 404,694 shares acquired at $24.71 apiece, for a total outlay of $10,000,000.01. This was not a grant, … Read more
Sanofi has disclosed a substantial open-market purchase of shares in Attovia Therapeutics, Inc. (ATTO), according to a Form 4 filed with the SEC. The filing shows Sanofi bought 300,000 shares on August 6, 2026 at a price of $17.00 per share, a transaction valued at $5,100,000.00. Following the purchase, Sanofi’s stake in Attovia stands at … Read more
Attovia Therapeutics, Inc. (NASDAQ: ATTO) is showing a fresh cluster of insider buying, with Redmile Group, LLC — a 10%+ owner of the company — disclosing an open-market purchase of 200,000 shares at $17.00 per share on August 6, 2026. The transaction, filed on Form 4, totaled $3,400,000 and brings Redmile Group’s directly held stake … Read more
A newly filed Form 4 with the Securities and Exchange Commission shows Kenta Kon, President and Director of Toyota Motor Corp (NYSE: TM), purchased 85,000 shares of the automaker’s stock on August 5, 2026. The transaction was executed on the open market, meaning Kon used his own funds to acquire the shares rather than receiving … Read more
Frazier Life Sciences XI, L.P., an insider at Attovia Therapeutics, Inc. (ATTO), disclosed an open-market purchase of 588,235 shares on August 6, 2026, according to a Form 4 filed with the SEC. The shares were bought at $17.00 apiece, for a total outlay of $9,999,995.00 — a purchase sized almost exactly to the $10 million … Read more
A newly filed Form 4 with the SEC shows Paul M. Meister, an insider at Aptiv PLC (NYSE: APTV), purchased 105,631 shares of the auto-technology supplier on August 5, 2026. The trade was executed at $47.33 per share, for a total outlay of $4,999,958.88 — just shy of the $5 million mark. This was an … Read more
A Form 4 filed with the Securities and Exchange Commission shows Lim Jung Jae, CEO, Interim CFO, and a director of Reborn Coffee, Inc. (NASDAQ: REBN), reported an open-market purchase of company stock dated July 14, 2026. According to the filing, Lim acquired 131,387 shares at a stated price of $180,000.00 per share, putting the … Read more